Premium
Definitive radiation therapy for squamous cell carcinoma of the soft palate
Author(s) -
Chera Bhishamjit S.,
Amdur Robert J.,
Hinerman Russell W.,
Morris Christopher G.,
Villaret Douglas B.,
Werning John W.,
Mendenhall William M.
Publication year - 2008
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.20848
Subject(s) - medicine , radiation therapy , stage (stratigraphy) , neck dissection , soft palate , surgery , basal cell , head and neck , survival rate , carcinoma , paleontology , biology
Background. We report the University of Florida experience with soft‐palate carcinoma treated with radiotherapy alone or combined with adjuvant chemotherapy and/or neck dissection for residual disease in the neck. Methods. A total of 145 patients treated with curative intent from 1963 to 2004 were included. Potential follow‐up was ≥2 years. Results. Local control rates at 5 years were: T1, 90%; T2, 91%; T3, 67%; T4, 57%. Nodal control rates at 5 years were: N0, 90%; N1, 82%; N2, 68%; N3, 71%. Ultimate local‐regional control rates at 5 years were: stage I, 89%; stage II, 88%; stage III, 96%; stage IVA, 63%; stage IVB, 43%. In multivariate analysis, overall treatment time significantly affected local and ultimate local‐regional control, and nodal stage significantly affected overall survival. Overall survival rate at 5 years was 44%. Cause‐specific survival rate at 5 years was 73%. Conclusions. The likelihood of cure after definitive radiotherapy is relatively high and is impacted by disease extent and overall treatment time. © 2008 Wiley Periodicals, Inc. Head Neck 2008
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom